| Patents for G01N 33 - Investigating or analysing materials by specific methods not covered by groups (393,632) |
|---|
| 10/04/2001 | WO2000047625A9 Humanized immunoglobulin reactive with b7 molecules and methods of treatment therewith |
| 10/04/2001 | WO2000044935A3 Multiplex real-time pcr |
| 10/04/2001 | WO2000043515A3 Methods of monitoring hiv drug resistance |
| 10/04/2001 | WO2000042074A9 Anti-ccr4 antibodies and methods of use therefor |
| 10/04/2001 | WO2000039279A9 Dna encoding a human melanin concentrating hormone receptor (mch1) and uses thereof |
| 10/04/2001 | WO2000033066A9 Apparatus and method for wireless gas monitoring |
| 10/04/2001 | WO2000017655A9 Water-soluble fluorescent semiconductor nanocrystals |
| 10/04/2001 | WO2000017623A8 A new hematological parameter |
| 10/04/2001 | WO2000017327A9 Terpene synthases |
| 10/04/2001 | WO2000015178A9 Computer implemented pharmacokinetics method and program |
| 10/04/2001 | WO2000007018A3 Three-hybrid screening method for ligand-protein interactions |
| 10/04/2001 | US20010027566 Transgenic animal model of basal cell carcinoma |
| 10/04/2001 | US20010027565 Capable of binding envelope protein of hepatitis virus; therapy and/or diagnostic tool for hepatitis infection |
| 10/04/2001 | US20010027277 Disposable lancet combined with a reagent carrying strip and a system for extracting and analysing blood in the body utilizing such a disposable lancet |
| 10/04/2001 | US20010027269 Liquid sampler and blood analyzer using the same |
| 10/04/2001 | US20010027187 Such as hydroxyethylated bis(trimethoxysilylpropyl)amine as well as modified polyamines for use as silylating agents in surface treatment of silica and in formation of nucleic acid arrays |
| 10/04/2001 | US20010027184 Serine/threonine protein kinase (H-SGK2) |
| 10/04/2001 | US20010027182 Spinocerebellar ataxia type 1 (SCA1); using chaperone proteins to aid in recognition/hydrolysis of mutant ataxin-1 by the proteasome; treating Alzheimer's, Parkinson's, prion disorders, dentatorubral-pallidoluysian atrophy and SCA1 |
| 10/04/2001 | US20010027156 Core for blood processing apparatus |
| 10/04/2001 | US20010027070 Method and system for tracking ship engine emmissions as a function of geographical location |
| 10/04/2001 | US20010026946 Preparing gas sensor device comprising crystalline colloidal array polymerized in hydrogel that undergoes volume change in response to gas, array having lattice spacing that changes as volume of hydrogel changes; environmental, medical diagnosis |
| 10/04/2001 | US20010026945 Microparticle enhanced light scattering agglutination assay |
| 10/04/2001 | US20010026944 Immunoassay system |
| 10/04/2001 | US20010026942 Detection of contaminants using self-contained devices employing target material binding dyes |
| 10/04/2001 | US20010026936 Apparatus for automatic measuring of water toxicity |
| 10/04/2001 | US20010026929 Microfluidic in-line labeling method for continuous-flow protease inhibition analysis |
| 10/04/2001 | US20010026927 Compounds or surface active agents with a phosphorylcholine group and another cationic group, and an antibody to the protein; without dilution while avoiding prozone phenomenon |
| 10/04/2001 | US20010026925 Isolated, biologically substantially pure and viable immunocopocytes and non-epithelial cells of lymphoid origin obtained from a small fecal sample |
| 10/04/2001 | US20010026924 Isolated, biologically substantially pure and viable immunocopocytes and non-epithelial cells of lymphoid origin obtained from a small fecal sample |
| 10/04/2001 | US20010026923 Isolated, biologically substantially pure and viable immunocopocytes and non-epithelial cells of lymphoid origin obtained from a small fecal sample |
| 10/04/2001 | US20010026922 Detecting an immune response to Streptococcus mutans or its antigen in a sample from a patient, and diagnosing on the basis of the presence or absence of the response |
| 10/04/2001 | US20010026920 Subsets of particles comprising different known amounts of ligand binding partner sepcific for analytes of interest; providing information relating to high-dose hook effects, dilutional linearity, interfering assay factors, etc. |
| 10/04/2001 | US20010026919 Contacting tagged target nucleic acids generated from tagged gene specific primers with an array of tag complements under hybridization conditions, and detecting hybridized tag target nucleic acid-tag complements |
| 10/04/2001 | US20010026917 DNA detection device |
| 10/04/2001 | US20010026915 Spectral changes in biopolymer |
| 10/04/2001 | US20010026796 TCL1 enhances Akt kinase activity and mediates its nuclear translocation |
| 10/04/2001 | US20010025789 Infrared radiation curing; improving stress resistance and edge corrosion protection |
| 10/04/2001 | US20010025786 Nitrogen oxide gas sensor |
| 10/04/2001 | US20010025484 Catalyst state detector for exhaust gas purifying catalyst |
| 10/04/2001 | EP1139267A2 Single point interaction screen to predict IC50 |
| 10/04/2001 | EP1139101A2 Immunoassay for c-reactive protein |
| 10/04/2001 | EP1139100A2 Reactive probe chip, composite substrate and method for fabrication of the same |
| 10/04/2001 | EP1139099A2 Alcohol sensor and operation method |
| 10/04/2001 | EP1139098A2 Gas sensor having a structure for the installation of a protective cover |
| 10/04/2001 | EP1138784A2 Method for determining the efficiency of nucleic acid amplifications |
| 10/04/2001 | EP1138783A2 Method for the efficiency-corrected real-time quantification of nucleic acids |
| 10/04/2001 | EP1138781A2 Method for Quantifying DNA binding activity of DNA binding proteins |
| 10/04/2001 | EP1138779A2 Methods of rapid screening of cytochrome CYP2C19 status using mephenytoin |
| 10/04/2001 | EP1138778A2 Methods of rapid screening of cytochrome CYP2C19 status using omeprazole |
| 10/04/2001 | EP1138766A2 Process for preparing major histocompatibility antigen class II protein and materials having the same immobilized thereon |
| 10/04/2001 | EP1138758A1 Method for measuring the concentration and composition of biomass, probe and cell |
| 10/04/2001 | EP1138692A1 Fragments of human chorionic gonadotropin (hcg) as immunoregulator |
| 10/04/2001 | EP1138392A2 Centrifuge bowl for separating particles |
| 10/04/2001 | EP1138048A1 Electrically conductive electroactive functionalized conjugated polymers, and uses thereof |
| 10/04/2001 | EP1138019A2 Method and system for general purpose analysis of experimental data |
| 10/04/2001 | EP1137949A1 Assays for compounds which increase phospholipase a2 activity |
| 10/04/2001 | EP1137948A1 Methods and compositions to lower plasma cholesterol levels |
| 10/04/2001 | EP1137947A2 Method for determining asthma susceptibility |
| 10/04/2001 | EP1137946A1 Use of vascular endothelial growth factor (vegf) |
| 10/04/2001 | EP1137945A1 Methods for detection of antiestrogen-resistant breast cancer |
| 10/04/2001 | EP1137944A2 Differential expression in primary breast cancer |
| 10/04/2001 | EP1137943A1 Cancer detection method and reagents |
| 10/04/2001 | EP1137942A2 Patterned binding of functionalized microspheres for optical diffraction-based biosensors |
| 10/04/2001 | EP1137940A1 Assays for ligands for nuclear receptors |
| 10/04/2001 | EP1137939A2 Immunoisolation of caveolae |
| 10/04/2001 | EP1137938A1 Methods of screening for agonists and antagonists of the hdpxu17 receptor |
| 10/04/2001 | EP1137937A1 Using hair to screen for breast cancer |
| 10/04/2001 | EP1137936A1 Apparatus and method for measuring the characteristics of an oilfield fluid or the like |
| 10/04/2001 | EP1137935A1 Detection of preharvest sprouting in cereal grains |
| 10/04/2001 | EP1137932A1 Electrochemical sensor |
| 10/04/2001 | EP1137926A1 Electrochemical noise technique for corrosion |
| 10/04/2001 | EP1137925A1 REMOTE EMISSIONS SENSING SYSTEM WITH IMPROVED NO x? DETECTION |
| 10/04/2001 | EP1137811A2 Methods of identifying point mutations in a genome |
| 10/04/2001 | EP1137809A1 Toxicity typing using embryoid bodies |
| 10/04/2001 | EP1137805A1 Methods of facilitating vascular growth |
| 10/04/2001 | EP1137804A1 Method for detecting in vitro a target substance in a sample comprising the labelling of said substance with a reporter gene and the sequences required for expressing said reporter gene in vitro |
| 10/04/2001 | EP1137802A1 Method for determining the activity of a substance using a functional test in vitro |
| 10/04/2001 | EP1137801A1 Method for detecting and/or quantifying a known function from a nucleic acid sample |
| 10/04/2001 | EP1137799A1 Method and compound for detecting low levels of microorganisms |
| 10/04/2001 | EP1137798A1 A method of isolating stem cells |
| 10/04/2001 | EP1137792A1 A recombinant vector expressing multiple costimulatory molecules and uses thereof |
| 10/04/2001 | EP1137783A2 Beta-1,3-galactosyltransferase homologs |
| 10/04/2001 | EP1137780A1 Therapeutic and diagnostic uses of protein tyrosine phosphatase tc-ptp |
| 10/04/2001 | EP1137779A2 Identification of senv genotypes |
| 10/04/2001 | EP1137774A2 Grnf4, a gdnf-related neurotrophic factor |
| 10/04/2001 | EP1137773A2 Growth factor homolog zvegf3 |
| 10/04/2001 | EP1137771A2 Methods for preventing cardiac hypertrophy and heart failure by inhibition of mef2 transcription factor |
| 10/04/2001 | EP1137769A1 T cells specific for target antigens and methods and vaccines based thereon |
| 10/04/2001 | EP1137766A1 Animal model for psoriasis for the prevention and treatment of psoriasis in humans |
| 10/04/2001 | EP1137757A1 Dna molecules encoding the melanocortin 5 receptor protein from rhesus monkey |
| 10/04/2001 | EP1137754A2 Method for constructing libraries of phenotypic profiles |
| 10/04/2001 | EP1137669A1 Squaric acid activated carrier usable for immobilisation of compounds containing amine groups |
| 10/04/2001 | EP1137665A1 Cark protein and nucleic acid molecules and uses therefor |
| 10/04/2001 | EP1137656A1 31 human secreted proteins |
| 10/04/2001 | EP1137652A2 Conjugates comprising galactose alpha 1,3 galactosyl epitopes and methods of using same |
| 10/04/2001 | EP1137442A1 Biologically active conjugates having a detectable reporter moiety and method of identification of said derivative |
| 10/04/2001 | EP1137419A1 Uses of 1-amino-3-(n,n-dimethylamino)-propylidene-1,1-bisphosphonic acid |
| 10/04/2001 | EP1137366A1 Body fat measurement system |
| 10/04/2001 | EP1137340A1 Composition and method for regulation of body weight and associated conditions |
| 10/04/2001 | EP1012325A4 Methods for the high-resolution identification of solvent-accessible amide hydrogens in polypeptides |